Angiotensin II-induced reduction in body mass is Ang II receptor mediated in association with elevated corticosterone

Growth Hormone and IGF Research

Volumn 20, Issue 4, 2010, Pages 282-288

  Ortiz, Rudy M ^a,b   Kobori, Hiroyuki ^b   Conte, Debra ^a   Navar, L Gabriel ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Angiotensin receptor; Cachexia; Glucocorticoids; Growth hormone; IGF1; Proteolysis

Indexed keywords

ANGIOTENSIN 1A RECEPTOR; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR; CORTICOSTERONE; GHRELIN; GROWTH HORMONE RECEPTOR; LOSARTAN; SOMATOMEDIN C;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CACHEXIA; CALORIC INTAKE; CALORIC RESTRICTION; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; CORTICOSTERONE RELEASE; DOWN REGULATION; EPIDIDYMIS FAT; FLUID INTAKE; FOOD INTAKE; GASTROCNEMIUS MUSCLE; GENE EXPRESSION; HEART VENTRICLE HYPERTROPHY; MALE; MUSCLE ATROPHY; NONHUMAN; PRIORITY JOURNAL; RAT; RETROPERITONEAL FAT; URINARY EXCRETION; URINE VOLUME; WEIGHT REDUCTION;

ANGIOTENSIN II; ANIMALS; BODY WEIGHT; CORTICOSTERONE; KIDNEY; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ANGIOTENSIN, TYPE 2; RECEPTORS, ANGIOTENSIN; RECEPTORS, SOMATOTROPIN;

EID: 77955422622     PISSN: 10966374     EISSN: 15322238     Source Type: Journal    
DOI: 10.1016/j.ghir.2010.03.003     Document Type: Article

References (40)

1. Porter J.P., Anderson J.M., Robison R.J., Phillips A.C. Effect of central angiotensin II on body weight gain in young rats. Brain Res. 2003, 959:20-28.
2. Porter J.P., Potratz K.R. Effect of intracerebroventricular angiotensin II on body weight and food intake in adult rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2004, 287:R422-R428.
3. Schakman O., Gilson H., de Coninck V., et al. Insulin-like growth factor-I gene transfer by electroporation prevents skeletal muscle atrophy in glucocorticoid-treated rats. Endocrinology 2005, 146:1789-1797.
4. Brink M., Anwar A., Delafontaine P. Neurohormonal factors in the development of catabolic/anabolic imbalance and cachexia. Int. J. Cardiol. 2002, 85:111-121.
5. Brink M., Chrast J., Price S.R., Mitch W.E., Delafontaine P. Angiotensin II stimulates gene expression of cardiac insulin-like growth factor I and its receptor through effects on blood pressure and food intake. Hypertension 1999, 34:1053-1059.
6. Brink M., Price S.R., Chrast J., et al. Angiotensin II induces skeletal muscle wasting through enhanced protein degradation and down-regulates autocrine insulin-like growth factor I. Endocrinology 2001, 142:1489-1496.
7. Brink M., Wellen J., Delafontaine P. Angiotensin II causes weight loss and decreases circulating insulin-like growth factor I in rats through a pressor-independent mechanism. J. Clin. Invest. 1996, 97:2509-2516.
8. Cassis L., Helton M., English V., Burke G. Angiotensin II regulates oxygen consumption. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2002, 282:R445-R453.
9. Cassis L.A., Huang J., Gong M.C., Daugherty A. Role of metabolism and receptor responsiveness in the attenuated responses to Angiotensin II in mice compared to rats. Regul. Pept. 2004, 117:107-116.
10. Cassis L.A., Marshall D.E., Fettinger M.J., Rosenbluth B., Lodder R.A. Mechanisms contributing to angiotensin II regulation of body weight. Am. J. Physiol. Endocrinol. Metab. 1998, 274:E867-E876.
11. Delafontaine P., Akao M. Angiotensin II as candidate of cardiac cachexia. Curr. Opin. Clin. Nutr. Metab. Care 2006, 9:220-224.
12. Delafontaine P., Lou H. Angiotensin II regulates insulin-like growth factor I gene expression in vascular smooth muscle cells. J. Biol. Chem. 1993, 268:16866-16870.
13. Song Y.-H., Li Y., Du J., Mitch W.E., Rosenthal N., Delafontaine P. Muscle-specific expression of IGF-1 blocks angiotensin II-induced skeletal muscle wasting. J. Clin. Invest. 2005, 115:451-458.
14. Gayan-Ramirez G., Vanderhoydonc F., Verhoeven G., Decramer M. Acute treatment with corticosteroids decreases IGF-1 and IGF-2 expression in the rat diaphragm and gastrocnemius. Am. J. Respir. Crit. Care Med. 1999, 159:283-289.
15. Ortiz R.M., Graciano M.L., Mullins J.J., Mitchell K.D. Aldosterone receptor antagonism alleviates proteinuria, but not malignant hypertension in Cyp1a1-Ren2 transgenic rats. Am. J. Physiol. Renal Physiol. 2007, 293:F1584-F1591.
16. Wing S.S., Goldberg A.L. Glucocorticoids activate the ATP-ubiquitin-dependent proteolytic system in skeletal muscle during fasting. Am. J. Physiol. Endocrinol. Metab. 1993, 264:E668-E676.
17. Auclair D., Garrel D.R., Chaouki Zerouala A., Ferland L.H. Activation of the ubiquitin pathway in rat skeletal muscle by catabolic doses of glucocorticoids. Am. J. Physiol. Cell Physiol. 1997, 272:C1007-C1016.
18. Isozaki Y., Mitch W.E., England B.K., Price S.R. Protein degradation and increased mRNAs encoding proteins of the ubiquitin-proteasome proteolytic pathway in BC3H1 myocytes require an interaction between glucocorticoids and acidification. PNAS 1996, 93:1967-1971.
19. Kanda F., Takatani K., Okuda S., Matsushita T., Chihara K. Preventive effects of insulinlike growth factor-I on steroid-induced muscle atrophy. Muscle Nerve 1999, 22:213-217.
20. Tiao G., Fagan J., Roegner V., et al. Energy-ubiquitin-dependent muscle proteolysis during sepsis in rats is regulated by glucocorticoids. J. Clin. Invest. 1996, 97:339-348.
21. Beauloye V., Ketelslegers J.M., Moreau B., Thissen J.P. Dexamethasone inhibits both growth hormone (GH)-induction of insulin-like growth factor-I (IGF-I) mRNA and GH receptor (GHR) mRNA levels in rat primary cultured hepatocytes. Growth Hormon. IGF Res. 1999, 9:205-211.
22. Luo J., Murphy L. Dexamethasone inhibits growth hormone induction of insulin-like growth factor-I (IGF-I) messenger ribonucleic acid (mRNA) in hypophysectomized rats and reduces IGF-I mRNA abundance in the intact rat. Endocrinology 1989, 125:165-171.
23. Heinrichs C., Yanovski J.A., Roth A.H., et al. Dexamethasone increases growth hormone receptor messenger ribonucleic acid levels in liver and growth plate. Endocrinology 1994, 135:1113-1118.
24. Anker S.D., Chua T.P., Ponikowski P., et al. Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia. Circulation 1997, 96:526-534.
25. Guron G., Friberg P., Wickman A., Brantsing C., Gabrielsson B., Isgaard J. Cardiac insulin-like growth factor I and growth hormone receptor expression in renal hypertension. Hypertension 1996, 27:636-642.
26. Kopchick J.J., Andry J.M. Growth hormone (GH), GH receptor, and signal transduction. Mol. Gene Metab. 2000, 71:293-314.
27. Talamantes F., Ortiz R.M. Structure and regulation of expression of the mouse growth hormone receptor. J Endocrinol. 2002, 175:55-59.
28. Daughaday W., Rotwein P. Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations. Endocr. Rev. 1989, 10:68-91.
29. Harrison-Bernard L.M., El-Dahr S.S., O'Leary D.F., Navar L.G. Regulation of angiotensin II type 1 receptor mRNA and protein in angiotensin II-induced hypertension. Hypertension 1999, 33:340-346.
30. Ortiz R.M., Wang T.J., Wade C.E. Influence of centrifugation and hindlimb suspension on testosterone and corticosterone excretion in rats. Aviat. Space Environ. Med. 1999, 70:499-504.
31. Kobori H., Ozawa Y., Suzaki Y., Nishiyama A. Enhanced intrarenal angiotensinogen contributes to early renal injury in spontaneously hypertensive rats. J. Am. Soc. Nephrol. 2005, 16:2073-2080.
32. Fraser R., James V.H., Brown J.J., Isaac P., Lever A.F., Robertson J.I. Effect of angiotensin and of frusemide on plasma aldosterone, corticosterone, cortisol and renin in man. Lancet 1965, 2:989-991.
33. Dufau M.L., Kliman B. Acute effects of angiotensin-II-amide on aldosterone and corticosterone secretion by morphine-pentobarbital treated rats. Endocrinology 1968, 83:180-183.
34. Muller H., Schweitzer N., Johren O., Dominiak P., Raasch W. Angiotensin II stimulates the reactivity of the pituitary-adrenal axis in leptin-resistant Zucker rats, thereby influencing the glucose utilization. Am. J. Physiol. Endocrinol. Metab. 2007, 293:E802-E810.
35. Sowers J., Tuck M., Asp N.D., Sollars E. Plasma aldosterone and corticosterone responses to adrenocorticotropin, angiotensin, potassium, and stress in spontaneously hypertensive rats. Endocrinology 1981, 108:1216-1221.
36. Mitch W.E., Bailey J.L., Wang X., Jurkovitz C., Newby D., Price S.R. Evaluation of signals activating ubiquitin-proteasome proteolysis in a model of muscle wasting. Am. J. Physiol. Cell Physiol. 1999, 276:C1132-C1138.
37. Ueno H., Yamaguchi H., Kangawa K., Nakazato M. Ghrelin: a gastric peptide that regulates food intake and energy homeostasis. Regul. Pept. 2005, 126:11-19.
38. Wren A.M., Small C.J., Ward H.L., et al. The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinology 2000, 141:4325-4328.
39. Nagaya N., Uematsu M., Kojima M., et al. Elevated circulating level of ghrelin in cachexia associated with chronic heart failure: relationships between ghrelin and anabolic/catabolic factors. Circulation 2001, 104:2034-2038.
40. Otto B., Tschop M., Heldwein W., Pfeiffer A.F., Diederich S. Endogenous and exogenous glucocorticoids decrease plasma ghrelin in humans. Eur. J. Endocrinol. 2004, 151:113-117.